Companies in #Antibody Therapeutics

Discovers and develops antibody therapeutics using high-throughput single cell analysis and microfluidic platforms for complex transmembrane proteins, bispecifics, and ADCs. Reported strong menopause medicine efficacy data (Phase 2) in August 2026.

Development of drugs from complete human antibodies. Surfaces and engineers rare antibodies from human biology for autoimmune diseases. Raised $75M Series A backed by Regeneron Ventures.

Kelun-Biotech (Sichuan Kelun-Biotech Biopharmaceutical) is a biologics / adc company. See today's news for the latest developments.

Memo Therapeutics is a Swiss clinical-stage biotech developing antibody-based therapies for viral infections and cancer. Its lead asset is anti-BK virus (BKV) antibody for kidney transplant recipients, with additional programs in CMV and oncology.